{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:06Z","timestamp":1792511466099,"version":"4.5.0"},"reference-count":240,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004418","name":"Vrije Universiteit Brussel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003887","name":"International Myeloma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cancer cells are under the surveillance of the host immune system. Nevertheless, a number of\u00a0immunosuppressive mechanisms allow tumors to escape protective responses and impose immune tolerance. Epigenetic alterations are central to cancer cell biology and cancer immune evasion. Accordingly, epigenetic modulating agents (EMAs) are being exploited as anti-neoplastic and immunomodulatory agents to restore immunological fitness. By simultaneously acting on cancer cells, e.g. by changing expression of tumor antigens, immune checkpoints, chemokines or innate defense pathways, and on immune cells, e.g. by remodeling the tumor stroma or enhancing effector cell functionality, EMAs can indeed overcome peripheral tolerance to transformed cells. Therefore, combinations of EMAs with chemo- or immunotherapy have become interesting strategies to fight cancer. Here we review several examples of epigenetic changes critical for immune cell functions and tumor-immune evasion and of the use of EMAs in promoting anti-tumor immunity. Finally, we provide our perspective on how EMAs could represent a game changer for combinatorial therapies and the clinical management of cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2021.652160","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T05:54:54Z","timestamp":1617083694000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential"],"prefix":"10.3389","volume":"12","author":[{"given":"Ken","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mondino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Lasarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Agirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Vanderkerken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Prosper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Breckpot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.devcel.2010.10.005","article-title":"Aberrant epigenetic landscape in cancer: how cellular identity goes awry","volume":"19","author":"Berdasco","year":"2010","journal-title":"Dev Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/path.4832","article-title":"Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy","volume":"241","author":"Liu","year":"2017","journal-title":"J Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tig.2015.10.007","article-title":"Lateral Thinking: How Histone Modifications Regulate Gene Expression","volume":"32","author":"Lawrence","year":"2016","journal-title":"Trends Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature19759","article-title":"Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode","volume":"538","author":"Wang","year":"2016","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","article-title":"The diverse roles of DNA methylation in mammalian development and disease","volume":"20","author":"Greenberg","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3953","article-title":"Dual Inhibition of DNA and Histone Methyltransferases Increases Viral Mimicry in Ovarian Cancer Cells","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1712514114","article-title":"Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden","volume":"114","author":"Stone","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","article-title":"Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer","volume":"171","author":"Topper","year":"2017","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/2162402x.2018.1484981","article-title":"Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects","volume":"7","author":"De Beck","year":"2018","journal-title":"Oncoimmunology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15424","article-title":"Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies","volume":"8","author":"San Jose-Eneriz","year":"2017","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0499-y","article-title":"Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression","volume":"25","author":"Segovia","year":"2019","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbcan.2015.06.009","article-title":"Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment","volume":"1865","author":"Lahmar","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage m1-m2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/CCO.0000000000000344","article-title":"Novel insights in the regulation and function of macrophages in the tumor microenvironment","volume":"29","author":"Bolli","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01977","article-title":"Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression","volume":"9","author":"Awad","year":"2018","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.778761","article-title":"Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor gamma-dependent macrophage differentiation","volume":"292","author":"Tikhanovich","year":"2017","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/srep40531","article-title":"Protein arginine methyltransferase 1 (PRMT1) represses MHC II transcription in macrophages by methylating CIITA","volume":"7","author":"Fan","year":"2017","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3727\/105221618X15372014086197","article-title":"PRMT1-Dependent Macrophage IL-6 Production Is Required for Alcohol-Induced HCC Progression","volume":"19","author":"Zhao","year":"2019","journal-title":"Gene Expr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e78045","DOI":"10.1371\/journal.pone.0078045","article-title":"Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes","volume":"8","author":"Kittan","year":"2013","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1920","article-title":"The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection","volume":"11","author":"Satoh","year":"2010","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.271","article-title":"Jmjd3 contributes to the control of gene expression in LPS-activated macrophages","volume":"28","author":"De Santa","year":"2009","journal-title":"EMBO J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217620","article-title":"Epigenetic regulation of the alternatively activated macrophage phenotype","volume":"114","author":"Ishii","year":"2009","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1038\/ncomms6733","article-title":"A chromatin activity-based chemoproteomic approach reveals a transcriptional repressome for gene-specific silencing","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.000950","article-title":"The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance","volume":"284","author":"Chen","year":"2009","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3257","article-title":"The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory","volume":"16","author":"Yoshida","year":"2015","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00092","article-title":"Regulation of Epigenetic Modifiers, Including KDM6B, by Interferon-gamma and Interleukin-4 in Human Macrophages","volume":"8","author":"Yildirim-Buharalioglu","year":"2017","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature11262","article-title":"A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response","volume":"488","author":"Kruidenier","year":"2012","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2010.11.002","article-title":"Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity","volume":"53","author":"Tausendschon","year":"2011","journal-title":"Cytokine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3231","article-title":"Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages","volume":"73","author":"Osawa","year":"2013","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2994","article-title":"Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages","volume":"72","author":"Movahedi","year":"2012","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000482","article-title":"Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression","volume":"185","author":"Feng","year":"2010","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.08.038","article-title":"The anacardic 6-pentadecyl salicylic acid induces macrophage activation via the phosphorylation of ERK1\/2, JNK, P38 kinases and NF-kappaB","volume":"29","author":"Gnanaprakasam","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/imcb.12203","article-title":"Histone deacetylase 2 is essential for LPS-induced inflammatory responses in macrophages","volume":"97","author":"Wu","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121131109","article-title":"Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1101\/gad.175950.111","article-title":"Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation","volume":"25","author":"Mullican","year":"2011","journal-title":"Genes Dev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E13-12-0757","article-title":"Glycolysis-dependent histone deacetylase 4 degradation regulates inflammatory cytokine production","volume":"25","author":"Wang","year":"2014","journal-title":"Mol Biol Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6820","article-title":"HDAC3 mediates smoking-induced pancreatic cancer","volume":"7","author":"Edderkaoui","year":"2016","journal-title":"Oncotarget"},{"key":"B40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/carcin\/bgs319","article-title":"The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer","volume":"34","author":"Tran","year":"2013","journal-title":"Carcinogenesis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0509363","article-title":"Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS","volume":"87","author":"Halili","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/me.2013-1293","article-title":"Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b","volume":"28","author":"Yang","year":"2014","journal-title":"Mol Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2013.12.023","article-title":"SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages","volume":"225","author":"Cheng","year":"2014","journal-title":"Toxicol Lett"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-4018","article-title":"DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer","volume":"79","author":"Travers","year":"2019","journal-title":"Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13720","article-title":"The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity","volume":"7","author":"Laoui","year":"2016","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.12688\/f1000research.14793.1","article-title":"Recent advances in understanding dendritic cell development, classification, and phenotype","volume":"7","author":"Schlitzer","year":"2018","journal-title":"F1000Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.206","article-title":"Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells","volume":"19","author":"Goyvaerts","year":"2012","journal-title":"Gene Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.imlet.2009.09.003","article-title":"Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth","volume":"127","author":"Lin","year":"2010","journal-title":"Immunol Lett"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3200","article-title":"Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow","volume":"16","author":"Schlitzer","year":"2015","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00260","article-title":"Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions","volume":"6","author":"Vu Manh","year":"2015","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00009","article-title":"Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How","volume":"10","author":"Cancel","year":"2019","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"Bottcher","year":"2018","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical Role for CD103(+)\/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0145-8","article-title":"Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific","volume":"19","author":"Michea","year":"2018","journal-title":"Nat Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/08923973.2019.1566925","article-title":"The role of T helper 17 and regulatory T cells in tumor microenvironment","volume":"41","author":"Najafi","year":"2019","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2826","article-title":"Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism","volume":"69","author":"Norian","year":"2009","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/s0198-8859(02)00748-6","article-title":"Human and mouse plasmacytoid dendritic cells","volume":"63","author":"Hochrein","year":"2002","journal-title":"Hum Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2271","article-title":"Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells","volume":"72","author":"Conrad","year":"2012","journal-title":"Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0684","article-title":"Dendritic cell infiltration and prognosis of early stage breast cancer","volume":"10","author":"Treilleux","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14315","article-title":"TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2008.14","article-title":"Monocyte-derived dendritic cells in innate and adaptive immunity","volume":"86","author":"Leon","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02804","article-title":"Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets","volume":"9","author":"Huber","year":"2018","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01119","article-title":"Chromatin Architecture as an Essential Determinant of Dendritic Cell Function","volume":"10","author":"Boukhaled","year":"2019","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000280","article-title":"Epigenetic Regulation of Dendritic Cell Development and Function","volume":"23","author":"Tian","year":"2017","journal-title":"Cancer J"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1101\/gr.192005.115","article-title":"Bacterial infection remodels the DNA methylation landscape of human dendritic cells","volume":"25","author":"Pacis","year":"2015","journal-title":"Genome Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112343","article-title":"Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response","volume":"209","author":"Fang","year":"2012","journal-title":"J Exp Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pupt.2017.10.004","article-title":"Long-acting beta2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation","volume":"48","author":"Kuo","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.07.011","article-title":"The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs","volume":"75","author":"Donas","year":"2016","journal-title":"J Autoimmun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3347","article-title":"Epigenetic regulation of the expression of Il12 and Il23 and autoimmune inflammation by the deubiquitinase Trabid","volume":"17","author":"Jin","year":"2016","journal-title":"Nat Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2011.87","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals chromatin state-based regulation of human monocyte-derived dendritic cells in different environments","volume":"13","author":"Huang","year":"2012","journal-title":"Genes Immun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12443","article-title":"Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer","volume":"13","author":"Zhou","year":"2019","journal-title":"Mol Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838674","article-title":"Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter","volume":"39","author":"Choi","year":"2009","journal-title":"Eur J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1128\/MCB.00805-14","article-title":"Cross talk between histone deacetylase 4 and STAT6 in the transcriptional regulation of arginase 1 during mouse dendritic cell differentiation","volume":"35","author":"Yang","year":"2015","journal-title":"Mol Cell Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344150","article-title":"Dendritic cell development requires histone deacetylase activity","volume":"44","author":"Chauvistre","year":"2014","journal-title":"Eur J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2217\/epi.15.118","article-title":"Histone deacetylase inhibitors as immunomodulators in cancer therapeutics","volume":"8","author":"Shen","year":"2016","journal-title":"Epigenomics"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.244","article-title":"HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells","volume":"25","author":"Song","year":"2011","journal-title":"Leukemia"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13059-015-0863-2","article-title":"IL-4 orchestrates STAT6-mediated DNA demethylation leading to dendritic cell differentiation","volume":"17","author":"Vento-Tormo","year":"2016","journal-title":"Genome Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8935-7-21","article-title":"DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells","volume":"7","author":"Zhang","year":"2014","journal-title":"Epigenet Chromatin"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161149","article-title":"Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7\/9-elicited IFN response in pDCs","volume":"214","author":"Ma","year":"2017","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2011.08.004","article-title":"Impact of the hypomethylating agent 5-azacytidine on dendritic cells function","volume":"39","author":"Frikeche","year":"2011","journal-title":"Exp Hematol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0080","article-title":"Antitumor Effects of Epidrug\/IFNalpha Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells","volume":"5","author":"Fragale","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00113","article-title":"Cancer-Associated Myeloid Regulatory Cells","volume":"7","author":"De Vlaeminck","year":"2016","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2012.01.011","article-title":"Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression","volume":"22","author":"Ostrand-Rosenberg","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/0008-5472.CAN-09-1882","article-title":"Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer","volume":"70","author":"Pan","year":"2010","journal-title":"Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-2395","article-title":"EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells","volume":"79","author":"Huang","year":"2019","journal-title":"Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1038\/s41467-019-10176-2","article-title":"Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2526","article-title":"Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer","volume":"14","author":"Youn","year":"2013","journal-title":"Nat Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.08.002","article-title":"Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function","volume":"63","author":"Sahakian","year":"2015","journal-title":"Mol Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.celrep.2019.03.008","article-title":"Regulation of Tumor-Associated Myeloid Cell Activity by CBP\/EP300 Bromodomain Modulation of H3K27 Acetylation","volume":"27","author":"de Almeida Nagata","year":"2019","journal-title":"Cell Rep"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.06.014","article-title":"Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells","volume":"137","author":"Xie","year":"2018","journal-title":"J\u00a0Pharmacol Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1935-1","article-title":"Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro","volume":"66","author":"Wang","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0741","article-title":"Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma","volume":"23","author":"Orillion","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0070","article-title":"Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs","volume":"6","author":"Christmas","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0311119","article-title":"Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo","volume":"91","author":"Rosborough","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.09.018","article-title":"Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells","volume":"21","author":"Rodriguez-Ubreva","year":"2017","journal-title":"Cell Rep"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2790-6","article-title":"Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment","volume":"145","author":"Zhou","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2394-6","article-title":"Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells","volume":"143","author":"Zhou","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00262-009-0786-4","article-title":"Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2\u2019-deoxycytidine","volume":"59","author":"Daurkin","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.07.014","article-title":"Epigenetic mechanisms regulating T-cell responses","volume":"142","author":"Schmidl","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3670","article-title":"Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy","volume":"14","author":"Coulie","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.022","article-title":"Epigenomic Profiling of Human CD4(+) T Cells Supports a Linear Differentiation Model and Highlights Molecular Regulators of Memory Development","volume":"45","author":"Durek","year":"2016","journal-title":"Immunity"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2016.19","article-title":"Promoter H3K4 methylation dynamically reinforces activation-induced pathways in human CD4 T cells","volume":"17","author":"LaMere","year":"2016","journal-title":"Genes Immun"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700475","article-title":"H3K27 Methylation Dynamics during CD4 T Cell Activation: Regulation of JAK\/STAT and IL12RB2 Expression by JMJD3","volume":"199","author":"LaMere","year":"2017","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/srep39785","article-title":"Rapid Recall Ability of Memory T cells is Encoded in their Epigenome","volume":"7","author":"Barski","year":"2017","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nature14154","article-title":"Super-enhancers delineate disease-associated regulatory nodes in T cells","volume":"520","author":"Vahedi","year":"2015","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.05.011","article-title":"Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization","volume":"38","author":"Hawkins","year":"2013","journal-title":"Immunity"},{"key":"B112","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.immuni.2019.01.003","article-title":"The Histone Methyltransferase SETDB1 Controls T Helper Cell Lineage Integrity by Repressing Endogenous Retroviruses","volume":"50","author":"Adoue","year":"2019","journal-title":"Immunity"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.09.012","article-title":"The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cells","volume":"39","author":"Tumes","year":"2013","journal-title":"Immunity"},{"key":"B114","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1038\/ncomms6780","article-title":"Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation","volume":"5","author":"Li","year":"2014","journal-title":"Nat Commun"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903610","article-title":"Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production","volume":"185","author":"Grausenburger","year":"2010","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-731505","article-title":"T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model","volume":"130","author":"Woods","year":"2017","journal-title":"Blood"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041130","article-title":"Rapamycin-sensitive signals control TCR\/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation","volume":"41","author":"Tomasoni","year":"2011","journal-title":"Eur J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.312785","article-title":"De novo DNA methylation is required to restrict T helper lineage plasticity","volume":"287","author":"Thomas","year":"2012","journal-title":"J Biol Chem"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.12.7377","article-title":"A distinct region of the murine IFN-gamma promoter is hypomethylated from early T cell development through mature naive and Th1 cell differentiation, but is hypermethylated in Th2 cells","volume":"173","author":"Winders","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/nature05563","article-title":"Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3646","article-title":"Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment","volume":"18","author":"Kitagawa","year":"2017","journal-title":"Nat Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.006","article-title":"Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases","volume":"52","author":"Ohkura","year":"2020","journal-title":"Immunity"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69592","article-title":"Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation","volume":"124","author":"Antignano","year":"2014","journal-title":"J Clin Invest"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 locus in regulatory T cells","volume":"5","author":"Floess","year":"2007","journal-title":"PloS Biol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.04.021","article-title":"Dynamic interactions between TIP60 and p300 regulate FOXP3 function through a structural switch defined by a single lysine on TIP60","volume":"7","author":"Xiao","year":"2014","journal-title":"Cell Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100903","article-title":"Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells","volume":"188","author":"Kwon","year":"2012","journal-title":"J Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/ijms21072356","article-title":"Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells","volume":"21","author":"von Knethen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.325332","article-title":"Polycomb antagonizes p300\/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner","volume":"287","author":"Xiong","year":"2012","journal-title":"J Biol Chem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.031","article-title":"Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus","volume":"158","author":"Feng","year":"2014","journal-title":"Cell"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.030","article-title":"Function of a Foxp3 cis-element in protecting regulatory T cell identity","volume":"158","author":"Li","year":"2014","journal-title":"Cell"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312717110","article-title":"Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation","volume":"111","author":"Morikawa","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-451765","article-title":"Foxp3+ T-regulatory cells require DNA methyltransferase 1 expression to prevent development of lethal autoimmunity","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.03.026","article-title":"Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes","volume":"36","author":"Bontkes","year":"2012","journal-title":"Leuk Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00488","article-title":"DNA Methyltransferase Inhibitor Promotes Human CD4(+)CD25(h)FOXP3(+) Regulatory T Lymphocyte Induction under Suboptimal TCR Stimulation","volume":"7","author":"Lu","year":"2016","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/418292","article-title":"5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity","volume":"2014","author":"Stubig","year":"2014","journal-title":"Mediators Inflammation"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.074823","article-title":"The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome","volume":"98","author":"Costantini","year":"2013","journal-title":"Haematologica"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12261","article-title":"Impact of 5-aza-2\u2019-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells","volume":"142","author":"Kehrmann","year":"2014","journal-title":"Immunology"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4973964","article-title":"DNA Methyltransferase Inhibition Promotes Th1 Polarization in Human CD4(+)CD25(high) FOXP3(+) Regulatory T Cells but Does Not Affect Their Suppressive Capacity","volume":"2018","author":"Landman","year":"2018","journal-title":"J Immunol Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.146","article-title":"Epigenetic control of CD8(+) T cell differentiation","volume":"18","author":"Henning","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161760","article-title":"Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis","volume":"214","author":"Abdelsamed","year":"2017","journal-title":"J Exp Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.32","article-title":"Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape","volume":"13","author":"Crompton","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/nature25144","article-title":"Effector CD8 T cells dedifferentiate into long-lived memory cells","volume":"552","author":"Youngblood","year":"2017","journal-title":"Nature"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.11.001","article-title":"Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation","volume":"41","author":"Russ","year":"2014","journal-title":"Immunity"},{"key":"B147","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2017.03.012","article-title":"Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8(+) T Cell Terminal Differentiation and Loss of Multipotency","volume":"46","author":"Gray","year":"2017","journal-title":"Immunity"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524490113","article-title":"De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation","volume":"113","author":"Ladle","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620498114","article-title":"Exhaustion-associated regulatory regions in CD8(+) tumor-infiltrating T cells","volume":"114","author":"Mognol","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/nature22367","article-title":"Chromatin states define tumour-specific T cell dysfunction and reprogramming","volume":"545","author":"Philip","year":"2017","journal-title":"Nature"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"B154","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural Killer Cells: Development, Maturation, and Clinical Utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01124","article-title":"The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy","volume":"8","author":"Paul","year":"2017","journal-title":"Front Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2018.06.004","article-title":"Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells","volume":"4","author":"Bugide","year":"2018","journal-title":"Trends Cancer"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1521740112","article-title":"Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity","volume":"112","author":"Yin","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16688","article-title":"Chromatin state dynamics during NK cell activation","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-013-1231-0","article-title":"The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells","volume":"32","author":"Zhu","year":"2015","journal-title":"Pharm Res"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404862","article-title":"Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells","volume":"21","author":"Kato","year":"2007","journal-title":"Leukemia"},{"key":"B162","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biocel.2018.03.004","article-title":"HDAC inhibitors as epigenetic regulators for cancer immunotherapy","volume":"98","author":"Conte","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.02.033","article-title":"Demethylating treatment suppresses natural killer cell cytolytic activity","volume":"46","author":"Gao","year":"2009","journal-title":"Mol Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1586\/1744666X.2014.865519","article-title":"Cellular and molecular mechanisms in cancer immune escape: a comprehensive review","volume":"10","author":"Bhatia","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B168","doi-asserted-by":"publisher","first-page":"e201908224","DOI":"10.1083\/jcb.201908224","article-title":"Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling","volume":"219","author":"Nguyen","year":"2020","journal-title":"J Cell Biol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.007","article-title":"The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy","volume":"20","author":"Zingg","year":"2017","journal-title":"Cell Rep"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e128474","DOI":"10.1172\/jci.insight.128474","article-title":"Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1-dependent mechanism","volume":"4","author":"Hamaidia","year":"2019","journal-title":"JCI Insight"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.d01-781.x","article-title":"3-Deazaadenosine analogues inhibit the production of tumour necrosis factor-alpha in RAW264.7 cells stimulated with lipopolysaccharide","volume":"89","author":"Jeong","year":"1996","journal-title":"Immunology"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171417","article-title":"Macrophage\/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3","volume":"215","author":"Zhang","year":"2018","journal-title":"J Exp Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7017","article-title":"Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors","volume":"165","author":"Magner","year":"2000","journal-title":"J Immunol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5270","article-title":"Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors","volume":"68","author":"Setiadi","year":"2008","journal-title":"Cancer Res"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0402-4","article-title":"Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells","volume":"57","author":"Khan","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"B178","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.leukres.2010.08.001","article-title":"Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers","volume":"35","author":"Dubovsky","year":"2011","journal-title":"Leuk Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7180","article-title":"Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells","volume":"7","author":"Gameiro","year":"2016","journal-title":"Oncotarget"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00081310","article-title":"A 5-aza-2\u2019-deoxycytidine\/valproate combination induces cytotoxic T-cell response against mesothelioma","volume":"38","author":"Leclercq","year":"2011","journal-title":"Eur Respir J"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/nature21409","article-title":"Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages","volume":"543","author":"Guerriero","year":"2017","journal-title":"Nature"},{"key":"B182","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s40425-019-0758-y","article-title":"Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition","volume":"7","author":"Mao","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11139","article-title":"JQ1, a BET-bromodomain inhibitor, inhibits human cancer growth and suppresses PD-L1 expression","volume":"43","author":"Liu","year":"2019","journal-title":"Cell Biol Int"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.08.032","article-title":"BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell Rep"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12788","article-title":"The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner","volume":"32","author":"Erkes","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1020","article-title":"Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer","volume":"7","author":"Adeegbe","year":"2017","journal-title":"Cancer Discov"},{"key":"B187","doi-asserted-by":"publisher","first-page":"e000337","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-004-0513-0","article-title":"An epigenetically altered tumor cell vaccine","volume":"53","author":"Khan","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-5-64","article-title":"An epigenetic vaccine model active in the prevention and treatment of melanoma","volume":"5","author":"Khan","year":"2007","journal-title":"J Transl Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"B192","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat Commun"},{"key":"B193","doi-asserted-by":"publisher","first-page":"14915","DOI":"10.1038\/s41598-017-14848-1","article-title":"Identification of pharmacological agents that induce HMGB1 release","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1302-4","article-title":"The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro","volume":"66","author":"Sonnemann","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105921","article-title":"BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma","volume":"76","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14802","article-title":"A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer","volume":"8","author":"Betancur","year":"2017","journal-title":"Nat Commun"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1792","article-title":"NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome","volume":"24","author":"Griffiths","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B198","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1158\/2326-6066.CIR-13-0126","article-title":"Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer","volume":"2","author":"Odunsi","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-015-1731-3","article-title":"A phase I trial combining decitabine\/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma","volume":"64","author":"Krishnadas","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-1054-9","article-title":"Histone deacetylase inhibitor AR-42 enhances E7-specific CD8(+) T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination","volume":"91","author":"Lee","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800885","article-title":"Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy","volume":"201","author":"Badamchi-Zadeh","year":"2018","journal-title":"J Immunol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1172\/Jci99760","article-title":"Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy","volume":"128","author":"Goswami","year":"2018","journal-title":"J Clin Invest"},{"key":"B203","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41388-018-0451-5","article-title":"Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade","volume":"38","author":"Qin","year":"2019","journal-title":"Oncogene"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0077-T","article-title":"HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade","volume":"3","author":"Woods","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-1068","article-title":"HDAC3 Inhibition Upregulates PD-L1 Expression in B-Cell Lymphomas and Augments the Efficacy of Anti-PD-L1 Therapy","volume":"18","author":"Deng","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-1302","article-title":"HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer","volume":"79","author":"Fukumoto","year":"2019","journal-title":"Cancer Res"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2283-0","article-title":"Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model","volume":"68","author":"Llopiz","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2091-y","article-title":"The class I\/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy","volume":"67","author":"Briere","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2584","article-title":"HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma","volume":"22","author":"Zheng","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B210","doi-asserted-by":"publisher","first-page":"e1466018","DOI":"10.1080\/2162402X.2018.1466018","article-title":"Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types","volume":"7","author":"Hicks","year":"2018","journal-title":"Oncoimmunology"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0125-3","article-title":"Decitibine improve the efficiency of anti-PD-1 therapy via activating the response to IFN\/PD-L1 signal of lung cancer cells","volume":"37","author":"Lai","year":"2018","journal-title":"Oncogene"},{"key":"B212","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41467-017-02630-w","article-title":"DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer","volume":"9","author":"Luo","year":"2018","journal-title":"Nat Commun"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1410626111","article-title":"Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells","volume":"111","author":"Kim","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3020","article-title":"De novo induction of a cancer\/testis antigen by 5-aza-2\u2019-deoxycytidine augments adoptive immunotherapy in a murine tumor model","volume":"66","author":"Guo","year":"2006","journal-title":"Cancer Res"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09225.x","article-title":"Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity","volume":"158","author":"Toor","year":"2012","journal-title":"Br J Haematol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1868-8","article-title":"DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer","volume":"65","author":"Terracina","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-2-8","article-title":"The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells","volume":"2","author":"Lisiero","year":"2014","journal-title":"J Immunother Cancer"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1456","article-title":"Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824","volume":"69","author":"Vo","year":"2009","journal-title":"Cancer Res"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2442","article-title":"Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer","volume":"71","author":"Rao","year":"2011","journal-title":"Cancer Res"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86437","article-title":"BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models","volume":"126","author":"Kagoya","year":"2016","journal-title":"J Clin Invest"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.06.008","article-title":"Rewriting History: Epigenetic Reprogramming of CD8(+) T Cell Differentiation to Enhance Immunotherapy","volume":"41","author":"Zebley","year":"2020","journal-title":"Trends Immunol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S198567","article-title":"Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma","volume":"12","author":"Li","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.02.014","article-title":"EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells","volume":"27","author":"Kailayangiri","year":"2019","journal-title":"Mol Ther"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.04.051","article-title":"Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System","volume":"23","author":"Avanzi","year":"2018","journal-title":"Cell Rep"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0874-1","article-title":"Cytokine IL-36gamma improves CAR T-cell functionality and induces endogenous antitumor response","volume":"35","author":"Li","year":"2020","journal-title":"Leukemia"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126199","article-title":"Endogenous T cells prevent tumor immune escape following adoptive T cell therapy","volume":"129","author":"Walsh","year":"2019","journal-title":"J Clin Invest"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N Engl J Med"},{"key":"B230","doi-asserted-by":"publisher","first-page":"e000329","DOI":"10.1136\/jitc-2019-000329","article-title":"TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma","volume":"8","author":"De Keersmaecker","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4121","article-title":"Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma","volume":"34","author":"Wilgenhof","year":"2016","journal-title":"J Clin Oncol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3747\/co.27.5283","article-title":"Chimeric antigen receptor T cell therapy comes to clinical practice","volume":"27","author":"Wall","year":"2020","journal-title":"Curr Oncol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02344-4","article-title":"Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment","volume":"22","author":"Rodriguez Perez","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.014.10122","article-title":"Immune checkpoint inhibitors in clinical trials","volume":"33","author":"Sharon","year":"2014","journal-title":"Chin J Cancer"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0505","article-title":"Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer","volume":"21","author":"Singh","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15707","article-title":"Mass spectrometry-based characterization of histones in clinical samples: applications, progresses, and challenges","author":"Noberini","year":"2021","journal-title":"FEBS J"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2914","article-title":"Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy","volume":"21","author":"Maio","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B238","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-019-0267-4","article-title":"Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise","volume":"17","author":"Morel","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.12.014","article-title":"Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome","author":"Oleksiewicz","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat Rev Drug Discov"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.652160\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T05:55:01Z","timestamp":1617083701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.652160\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":240,"alternative-id":["10.3389\/fimmu.2021.652160"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.652160","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"article-number":"652160"}}